Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05119452Not ApplicableUnknown

Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis

Role: collaborator

NCT03378843Completed

Spermidine Intake and All-cause Mortality

Role: collaborator

NCT01146587Not ApplicableSuspended

Comparative Study of GangTrainer GT1, Lokomat and Conventional Physiotherapy

Role: collaborator

NCT01452867Not ApplicableCompleted

Comparison of Ventilation With Bag-Valve-Mask, Laryngeal Tube S-D and Laryngeal Mask Airway Supreme

Role: lead

All 4 trials loaded